These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prognostic value of SYNTAX score for outcomes and revascularization strategy choice in ST-segment elevation myocardial infarction patients with multivessel coronary artery disease]. Tarasov RS, Ganiukov VI, Shilov AA, Barbarash OL, Barbarash LS. Ter Arkh; 2012; 84(9):17-21. PubMed ID: 23091848 [Abstract] [Full Text] [Related]
4. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW. J Am Coll Cardiol; 2014 May 13; 63(18):1845-54. PubMed ID: 24561145 [Abstract] [Full Text] [Related]
6. [Effect of the terms of complete revascularization on the outcomes of treatment of patients with st segment elevation myocardial infarction and multivessel coronary artery disease]. Tarasov RS, Ganiukov VI, Popov VA, Shushpannikov PA, Barbarash OL, Barbarash LS. Angiol Sosud Khir; 2013 May 13; 19(4):14-20. PubMed ID: 24429555 [Abstract] [Full Text] [Related]
8. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention. Güngör B, Alper AT, Ozcan KS, Ekmekçi A, Karadeniz FÖ, Mutluer FO, Kaya A, Karataş B, Osmonov D, Bolca O. Catheter Cardiovasc Interv; 2014 Nov 15; 84(6):965-72. PubMed ID: 24402881 [Abstract] [Full Text] [Related]
9. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, Garcia-Garcia HM, Parrinello G, Campo G, Valgimigli M, STRATEGY and MULTISTRATEGY Investigators. JACC Cardiovasc Interv; 2011 Jan 15; 4(1):66-75. PubMed ID: 21251631 [Abstract] [Full Text] [Related]
13. New Predictors of Early and Late Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Unprotected Left Main Coronary Artery Culprit Lesion. Homorodean C, Iancu AC, Leucuţa D, Bãlãnescu Ş, Dregoesc IM, Spînu M, Ober M, Tãtaru D, Olinic M, Bindea D, Olinic D. J Interv Cardiol; 2019 Jan 15; 2019():8238972. PubMed ID: 31772547 [Abstract] [Full Text] [Related]